Doxorubicin + Trabectedin
Sep 05, 2024•17 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
LMS04 final OS results are published for doxorubicin + trabectedin in Leiomyosarcoma. Plus, a natural experiment of what happens in small cell lung cancer during an IV etoposide shortage. Finally, a nice paper provides some examples of how oncology pharmacists can bridge the care gap between oncology and primary care.
LMS04: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2403394
IV etoposide shortage: https://doi.org/10.1200/OP.24.00394
Primary care - oncology pharmacy collaboration: https://doi.org/10.1177/10781552241279303
For the best experience, listen in Metacast app for iOS or Android